Recently 1-hydroxyacridone derivatives were described as a new class of non-nucleoside inhibitors of Herpes Simplex Virus-1 (HSV-1), the agent of the most common human diseases. Based on these molecules, we applied rigid analogue and isosteric replacement approaches to design and synthesize five new benzo [b]thieno[3,2-h]-1,6-naphthyridines derivatives 8a-e as feasible anti-HSV prototypes. Herein we described the synthesis of this series of compounds and a theoretical evaluation of the drug score and drug likeness of these compounds by using an in silico ADMET screening.
Introduction
Herpes simplex Virus 1 and 2 (HSV-1 and HSV-2) are agents of the most common humans diseases that include keratoconjutivicts, encephalitis, oral and genital infections.
1-4 Current clinical anti-herpes virus compounds used for the treatment of the HSV symptomatic recurrent hydroxyacridones II [22] [23] [24] as being active against HSV-1. These compounds include 5-chloro-1,3-dihydroxyacridone (ED 50 = 4±1 µM) possessing remarkable activity against Herpes simplex virus type 1 (HSV-1). [22] [23] [24] Recently our group described the synthesis of new derivatives of ethyl In this work, we used traditional medicinal chemistry principles, such as isosteric replacement and rigid analogue approaches, to design a new potentially antiviral benzo [b] thieno[3,2-h]-1,6-naphthyridine scaffold ( Figure 2 ). The designing of this scaffold was based on two heterocycles, ethyl 4-(phenylamino)thieno [2,3-b] pyridine-5-carboxylate III, presenting anti-HSV-1 activity among a diverse antiviral profile, 25 and synthetic 1-hydroxyacridone derivatives IV with anti-HSV-1 activity. [25] [26] [27] [28] [29] [30] 
Figure 2
To investigate the impact of replacing the isosteric aromatic ring and the influence of the restricted flexibility imposed by the new benzo[b]thieno[3,2-h]-1,6-naphthyridine system, the compounds were submitted to an in silico ADMET screening to theoretically evaluate the drug score and drug likeness compared to acyclovir, a commercial antiviral drug, and 5-chloro-1,3-dihydroxyacridone.
Results and Discussion
Initially, 2-nitrothiophene 1 (Scheme 1) was reduced with tin and hydrochloric acid, leading to bis-(2-thienylammonium)hexachlorostannate 2. This compound was immediately condensed with ethyl (ethoxymethylene)cyanoacetate in pyridine at 40-50 o C over a period of 24 hours to produce ethyl α-cyano-β-(N-2-thienylammonium)acrylate 3 in 88% yield. 
In silico ADMET screening
The five benzo[b]thieno[3,2-h]-1,6-naphthyridine derivatives 8a-e were submitted to an in silico ADMET screening (http://www.organic-chemistry.org/prog/peo/ and http://www.molinspiration.com/cgi-bin/properties) to analyze their overall potential drug likeness and drug score compared to the 5-chloro-1,3-dihydroxyacridone and the commercial antiviral drug, acyclovir. Therefore, we evaluated some parameters such as: a) the cLogP value, which refers to the molecular hydrophobicity and that affects drug absorption, bioavailability, hydrophobic drug-receptor interactions, metabolism of molecules, as well as their toxicity, b) the Lipinski "Rule of 5", which states that most "drug-like" molecules have logP <= 5, molecular weight <= 500, number of hydrogen bond acceptors <= 10, and number of hydrogen bond donors <= 5; c) the toxicity risks (mutagenic, tumorigenic, and reproductive effects), d) the drug likeness value determined within the Fluka traded drugs collection, and e) the drug score that combines drug likeness, c log P, log S, molecular weight, and toxicity risks, and theoretically may be used to evaluate the drug potential of a compound 29 According to our theoretical study, the naphthyridine derivatives 8a-e show low tumorgenicity, mutagenicity and reproductive effects profiles (green scale) similar to acyclovir and the 5-chloro-1,3-dihydroxyacridone (not shown). It is important to notice that the toxicity predicted herein neither is a fully reliable toxicity prediction, nor guarantees that these compounds are completely free of any toxic effect. However, it reinforces the promising profile of these compounds for further experimental investigation 27, 28 .
Conclusions
In acridones, the variation of the functional groups has impact on the activity as described in the literature. Due to the isosteric replacement and rigid analogue structure, the new series of benzo [b] thieno[3,4-h]-1,6-naphthyridines reported herein may have the potential to display an anti-HSV-1 profile. Although the Osiris risk alerts are not a fully reliable toxicity prediction, the theoretical low-toxicity profile of these compounds and their analogous drug likeness and drug score values compared to acyclovir and 5-chloro-1,3-dihydroxyacridone may suggest the potentiality of these compounds as new antiviral prototypes to be further investigated. 31 A mixture of the acids derivatives (7 a-e) (2 mmol) and phosphorus oxychloride (5 mL) was heated under reflux for 3 hours. The reaction mixture was poured over crushed ice. In some cases the excess of phosphorus oxychloride was removed under reduced pressure before invert crushed ice and neutralized with water. 
